Registered Cardiovascular Invasive Specialist (RCIS) Practice Test

Heparin is an anticoagulant that works by inhibiting certain clotting factors in the blood, specifically factors Xa and IIa (thrombin), which play a crucial role in the coagulation cascade. By inhibiting these factors, heparin effectively prolongs the time it takes for blood to clot, which consequently increases bleeding time. This is particularly important in clinical scenarios where management of thromboembolic events is necessary.

Understanding the mechanism of heparin provides clarity for its impact on bleeding. While it is true that heparin serves as an important therapeutic agent in preventing blood clots, its influence on the coagulation process directly correlates with increased bleeding time. In clinical practice, this information is crucial for healthcare providers when monitoring patients receiving heparin therapy to avoid excessive bleeding complications.